The advertisement promotes NUBEQA, highlighting its approval for a new use in treating men with prostate cancer that has metastasized. It includes a safety information disclaimer.
Creative Information
| CID: | 1393a8d2-be50-4a12-9ac4-e0adcb175e51 |
| CRID: | 82_1075-793606 |
| Domain: | nubeqa-us.com |
| Seat: | PP |
| Size: | 160x600 |
| Bid: | $2.22 |
| Timestamp: | 11/7/2025, 5:10:57 PM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 11/7/2025, 6:39:13 PM | 6.28s | |
| adomain_analysis | success | 11/7/2025, 8:33:31 PM | 3.02s | |
| adomain_capture | success | 11/7/2025, 8:33:28 PM | 0.04s | |
| ad_render | success | 11/7/2025, 6:39:06 PM | 24.58s | |
| brand_mapping | success | 11/7/2025, 5:10:57 PM | 0.13s | |
Analysis Results
Ad Format: banner
Brands: Nubeqa
Sensitive:Pharmaceutical Products
Quality:Adomain not match landing page domain
| Size: | 160x600 | ||||||||||||||||||||||
| Data Transferred: | 1015.84 KB | ||||||||||||||||||||||
| Render Time: | 8.86 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Landing Page: | |||||||||||||||||||||||
| Total Ad Size: | 1016.06 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain
Ad Preview
Landing Page
Creatives
